Share Facebook Twitter LinkedIn Pinterest Email Decisions were “finely balanced” and, with hindsight, might have been different, Fiona Scolding KC says.
Gene therapy R&D market projected to grow through 2035 across multiple disease areas led by firms such as BlueRock TherapeuticsJanuary 8, 2026
By Michael
